Navigation Links
Recent Study Reveals Benefits to Women From DHEA Hormone
Date:1/24/2012

CHARLESTON, S.C., Jan. 24, 2012 /PRNewswire/ -- Leading age management facility, Cenegenics Carolinas, located in Charleston (age management Charleston) and Charlotte (age management Charlotte) is encouraged by a recent study suggesting low doses of the hormone DHEA may help sexual function and menopausal symptoms in women.

In the yearlong study, published in the December issue of the International Menopause Society journal Climacteric, Italian researchers followed a group of 48 menopausal women and found that low-doses of DHEA can help relieve menopausal symptoms in women while also improving their sex lives.

DHEA (dehydroepiandrosterone) is a natural steroid hormone produced primarily by the adrenal glands and is one of the principal hormone levels Cenegenics Carolinas focuses on in their bioidentical hormone replacement therapy (hormone therapy Charleston, hormone therapy Charlotte).

"We are pleased by the recent findings of the new study on DHEA and its benefits," said Mickey Barber, CEO and CMO of Cenegenics Carolinas. "While this study provides new insight into the function of hormones in relation to age management, it is important to note that DHEA should only be used under the supervision of a doctor trained in DHEA supplementation."

About Cenegenics Carolinas
Cenegenics Carolinas is a Charleston-based medical institute that helps patients manage the aging process through a customized regimen of exercise, nutrition and hormone optimization to improve their quality of life and help them feel healthy and years younger than their age. CEO Mickey Barber, MD, a board-certified anesthesiologist, former assistant professor at Tulane University and leading healthy aging physician in the Carolinas, heads Cenegenics Carolinas, the first Cenegenics center in the country. For more information about Cenegenics Carolinas, call (843) 724-7272 or visit www.cenegenicscarolinas.com.


'/>"/>
SOURCE Cenegenics Carolinas
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
2. vRad Radiology Alliance Continues to Transform Radiology With Most Recent Practice Partnership
3. Ampio Responds to Recent Publications by Anonymous Short Sellers
4. Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline
5. K-V Pharmaceutical Company Comments on Recent Settlement With the Department of Justice
6. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
7. China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Companys Convertible Notes in August 2008
8. Recent Research Provides Formula for Timely Product Launch: Good Science + Effective FDA Relations
9. Prime Therapeutics Launches CareCentered Contracting™ Program
10. Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix
11. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):